Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
Gastroenterology|July 15, 2009
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximabWilliam J Sandborn, Paul Rutgeerts, Brian G Feagan, et al.
Therapeutic Advances in Gastroenterology|October 13, 2025
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysisMarc Ferrante, Laurent Peyrin-Biroulet, Perttu Arkkila, et al.
Journal of Crohn'S & Colitis|September 22, 2023
Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn's Disease Patients: A Prospective Open-label StudyGeert D'Haens, Michael Eberhardson, Zeljko Cabrijan, et al.
The New England Journal of Medicine|September 29, 2021
Ozanimod as Induction and Maintenance Therapy for Ulcerative ColitisWilliam J Sandborn, Brian G Feagan, Geert D'Haens, et al.
Gastroenterology|March 7, 2016
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic ResectionMiguel Regueiro, Brian G Feagan, Bin Zou, et al.
The American Journal of Clinical Nutrition|June 10, 2016
Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitisKatherine Meckel, Yan Chun Li, John Lim, et al.
Inflammatory Bowel Diseases|October 14, 2003
Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypesSteven R Brant, Michael F Picco, Jean-Paul Achkar, et al.
Inflammatory Bowel Diseases|May 3, 2018
Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease: An International Multicenter StudyEmma Calabrese, Torsten Kucharzik, Christian Maaser, et al.
Inflammatory Bowel Diseases|February 8, 2013
Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesionsJoel Pekow, Urszula Dougherty, Yong Huang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 5, 2015
Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled TrialsJennifer L Jones, Gilaad G Kaplan, Laurent Peyrin-Biroulet, et al.
Pageof 22